Skip to main content
Clinical Trials/ACTRN12608000410358
ACTRN12608000410358CompletedPhase 3

A single-blind randomised controlled trial of nicotine-free cigarettes as an adjunct to usual nicotine replacement therapy (NRT)-based cessation practice (patch, gum and/or lozenge), in people who wish to stop smoking.

Heath Research Council NZ0 sites1,410 target enrollmentStarted: August 21, 2008Last updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
1,410

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • 1. they want to stop smoking
  • 2. they are at least 18 years of age
  • 3. their time to first cigarette is within 30 minutes of waking
  • 4. they are able to provide verbal consent
  • 5. they have access to a telephone

Exclusion Criteria

  • Pregnant and breastfeeding women and smokers who have had a heart attack, stroke, or unstable angina within the last two weeks will be excluded, as will smokers who are current users of NRT products, those who use only non-cigarette tobacco products (e.g. pipes, cigars), those who are currently using non nicotine-based cessation therapies (e.g. buproprion [Zyban], clonidine, nortriptyline, or varenicline [Champix]), and those who are current clients of Txt2Quit and NRT Online.

Investigators

Sponsor
Heath Research Council NZ

Similar Trials